• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE Back to Search Results
Model Number 777426
Device Problems Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Micturition Urgency (1871); Urinary Frequency (2275); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/27/2021
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the patient had an indwelling ureteral stent for drainage due to the operation of left kidney stone on (b)(6) 2021.Patient experienced hematuria, frequent urination, urgency, and dysuria repeatedly after the operation.The symptoms could be relieved by anti-inflammatory treatment, but they recurred from time to time.On (b)(6) 2022, the ureteral stent was removed.During the operation, the surface of the ureteral stent was covered with a large number of small stones, and there was a lot of pus moss on the surface.The patient experienced no significant discomfort after the surgery.It was mentioned that recurrent urinary tract infection and stone crystal deposition resulted due to foreign body reaction after indwelling the ureteral stent.
 
Manufacturer Narrative
The reported event was inconclusive because no sample was returned for evaluation.A potential root cause for this event could be, "material selection".The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: ""the insertion of a ureteral stent should only be done by those individuals who have comprehensive training in the techniques and risks of the procedure." "potential complications associated with retrograde/antegrade positioning of indwelling ureteral stents include the following: ¿ edema ¿ stone formation ¿ peritonitis ¿ extravasation ¿ ureteral reflux ¿ stent dislodgement, fragmentation, migration, occlusion ¿ fistula formation ¿ loss of renal function ¿ hemorrhage ¿ pain/discomfort ¿ stent encrustation ¿ hydronephrosis ¿ perforation of kidney, renal pelvis, ureter and/or bladder ¿ ureteral erosion ¿ infection ¿ urinary symptoms" "determine the proper stent length for the patient.This is generally calculated from the baseline pyelogram.Accurate measurements will optimize drainage efficiency and patient comfort.Submerge stent in sterile water to activate the coating." h11: section a through f - the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that the patient had an indwelling ureteral stent for drainage due to the operation of left kidney stone on (b)(6) 2021.Patient experienced hematuria, frequent urination, urgency, and dysuria repeatedly after the operation.The symptoms could be relieved by anti-inflammatory treatment, but they recurred from time to time.On (b)(6) 2022, the ureteral stent was removed.During the operation, the surface of the ureteral stent was covered with a large number of small stones, and there was a lot of pus moss on the surface.The patient experienced no significant discomfort after the surgery.It was mentioned that recurrent urinary tract infection and stone crystal deposition resulted due to foreign body reaction after indwelling the ureteral stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington 30014
7707846100
MDR Report Key13719978
MDR Text Key286920346
Report Number1018233-2022-01190
Device Sequence Number1
Product Code FAD
UDI-Device Identifier10801741014489
UDI-Public(01)10801741014489
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number777426
Device Catalogue Number777426
Device Lot NumberNGFR5510
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2022
Initial Date FDA Received03/10/2022
Supplement Dates Manufacturer Received06/07/2022
Supplement Dates FDA Received06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexMale
-
-